StockReport.com is a 7:00 PM newsletter with a pertinent stock report every day, plus the lates market news.
Indivior plc is a specialty pharmaceutical company dedicated to developing and delivering treatments for addiction and related mental health disorders. The company’s portfolio centers on therapies designed to support individuals dealing with opioid dependence, alcohol use disorder and other behavioral health challenges. Its lead products include Suboxone® (buprenorphine and naloxone) sublingual film and Sublocade® (extended-release buprenorphine) injection, both of which are approved in multiple markets to aid in opioid use disorder management.
Indivior was established in 2014 through a demerger from the pharmaceuticals division of Reckitt Benckiser Group plc, inheriting decades of research and commercial expertise in addiction medicine. The company is headquartered in Slough, United Kingdom, with a major operations and manufacturing hub in Richmond, Virginia. Since its inception, Indivior has sought to expand access to evidence-based treatments through ongoing clinical research and strategic collaborations.
Beyond its core opioid dependence offerings, Indivior maintains a pipeline of investigational therapies aimed at addressing alcohol use disorder and other psychiatric conditions. The company invests in clinical development programs to explore novel formulations, delivery technologies and digital health solutions intended to enhance treatment adherence and patient outcomes.
Today, Indivior markets its products across North America, Europe, Australia and other key regions, supporting healthcare professionals with educational and patient-support initiatives. Through its global footprint, the company aims to reduce barriers to care and improve long-term recovery rates for individuals affected by addiction worldwide.
Tencent Music Entertainment Group (NYSE: TME) is China’s music streaming leader, amassing a huge market share. The entertainment company boasts approximately 528 million monthly active users (MAUs) and generated $1 billion in revenue from online music services in its latest quarter. Meanw...
All eyes are on the initial public offering (IPO) calendar as one of 2026’s most highly anticipated debuts prepares for its launch. On April 1, CNBC reported that Tesla (NASDAQ: TSLA) and Neuralink CEO Elon Musk confidentially filed an IPO for SpaceX with the U.S. Securities and Exchan...
This year’s exodus from tech stocks and other growth-focused corners of the market has been well-documented. But after the NASDAQ and Dow Jones Industrial Average both entered a correction last week, it is increasingly evident that Main Street is feeling the pinch just as much as Wall Street...
Even amidst market uncertainty, risk-tolerant investors may want to look at opportunities in stocks trading under $20. With broad market volatility persisting through the first quarter of 2026, it can feel tough to find growth outside of energy stocks. But history consistently shows that buying q...